CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE4204.00-37.15 (-0.88 %)
PREV CLOSE () 4241.15
OPEN PRICE () 4253.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1271
TODAY'S LOW / HIGH ()4191.35 4258.70
52 WK LOW / HIGH ()4145.9 6717.5
NSE4197.60-44.6 (-1.05 %)
PREV CLOSE() 4242.20
OPEN PRICE () 4259.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 4197.60 (12)
VOLUME 18759
TODAY'S LOW / HIGH() 4190.70 4259.80
52 WK LOW / HIGH ()4219.5 6717
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1956

Management Info :

Aditya Narayan - Chairman - Managing Director

Registered Office :

Address : Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone : 022-2803 2000

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
29Oct Sanofi India informs about presentation
With reference to intimation dated 23rd October 2025, informing about th..
27Oct Appointment of Director
Iinter-alia considered and approved the following matter(s): 1. Upon..
18Jul Sanofi India informs about board meeti
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..
24May Sanofi India informs about change in m
Sanofi India has informed that upon the recommendation of the Nomination..
25Apr Sanofi India informs about disclosure
In compliance with Regulation 30 of the SEBI (LODR) Regulations, Sanofi..
Financials
in Millions
QTR Sep 25 ANNUAL 24
Net Profit7604135
Gross Profit 1023 4314
Operating Profit 13915073
Net Sales 475420132
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 16500.00 (2.63%)
M.Cap ( in Cr)
21169.32
CORONA Remedies (BSE)
 1437.20 (35.33%)
M.Cap ( in Cr)
8789.93
Procter&Gamble Healt (BSE)
 5663.25 (1.51%)
M.Cap ( in Cr)
9400.65
Fredun Pharma (BSE)
 1660.40 (5.00%)
M.Cap ( in Cr)
783.98
RPG Life Sciences (BSE)
 2375.00 (2.90%)
M.Cap ( in Cr)
3928.02
Shareholding Pattern
PROMOTERS 60.4%
FI/BANKS/INSURANCE 11.86%
NON-INSTITUTION 11.75%
MUTUAL FUNDS/UTI 10.42%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX85213.36-54.30 (-0.06%)
NIFTY26027.30-19.65 (-0.08%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI